<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04842123</url>
  </required_header>
  <id_info>
    <org_study_id>ECG-002</org_study_id>
    <nct_id>NCT04842123</nct_id>
  </id_info>
  <brief_title>Electrocardiogram Clinical Validation Study</brief_title>
  <official_title>Electrocardiogram Clinical Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Garmin International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Garmin International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to confirm the Garmin ECG (electrocardiogram) software algorithm&#xD;
      can detect and classify atrial fibrillation and normal sinus rhythm on single lead ECG data&#xD;
      derived from a Garmin wrist-worn, consumer device. The study will also confirm the software's&#xD;
      ability to create a Lead I ECG that is clinically equivalent to a reference device. The&#xD;
      Garmin ECG software is not a diagnostic system and is intended for informational purposes&#xD;
      only.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2021</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity of rhythm classification</measure>
    <time_frame>1 Day</time_frame>
    <description>Number of participants with a SR software rhythm classification in agreement with a physician's interpretation of heart rhythm based on gold standard 12-lead ECG</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity of rhythm classification</measure>
    <time_frame>1 Day</time_frame>
    <description>Number of participants with an AF software rhythm classification in agreement with a physician's interpretation of heart rhythm based on gold standard 12-lead ECG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of ECGs that pass a visual overlay</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of participants with software's ability to produce a clinically equivalent waveform in agreement to a gold standard Lead I reference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in R-wave amplitudes between the software and gold standard reference</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of participants with software's ability to produce a clinically equivalent waveform in agreement to a gold standard Lead I reference</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with a known history of AF who are in AF at the time of study screening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Sinus Rhythm (SR)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with no known diagnosis of AF or other arrhythmia</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Electrocardiogram</intervention_name>
    <description>Simultaneous assessment of the heart rhythm determined from a 12-lead ECG and the Garmin ECG software algorithm heart rhythm classification on single-lead ECG data derived from the wearable device. All participants will record three simultaneous 12-lead and single-lead ECGs.</description>
    <arm_group_label>Atrial fibrillation (AF)</arm_group_label>
    <arm_group_label>Normal Sinus Rhythm (SR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to read, understand, and provide written informed consent;&#xD;
&#xD;
          -  Willing and able to participate in the study procedures as described in the consent&#xD;
             form;&#xD;
&#xD;
          -  Individuals who are 22 years of age and older;&#xD;
&#xD;
          -  Able to communicate effectively with and follow instructions from the study staff;&#xD;
&#xD;
          -  Have a wrist circumference that fits within the device band; and&#xD;
&#xD;
          -  For subjects enrolled into the AF population, subjects must have a known diagnosis of&#xD;
             AF and be in AF at the time of screening.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Physical disability that precludes safe and adequate testing;&#xD;
&#xD;
          -  Mental impairment resulting in limited ability to cooperate;&#xD;
&#xD;
          -  Subjects with a pacemaker or implantable cardioverter-defibrillator (ICD);&#xD;
&#xD;
          -  Acute myocardial infarction within 90 days of screening or other cardiovascular&#xD;
             disease that, in the opinion of the Investigator, increases the risk to the subject or&#xD;
             renders data uninterpretable;&#xD;
&#xD;
          -  Acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis within 90 days&#xD;
             of screening;&#xD;
&#xD;
          -  Stroke or transient ischemic attack within 90 days of screening;&#xD;
&#xD;
          -  Subjects taking rhythm control drugs;&#xD;
&#xD;
          -  Symptomatic (or active) allergic skin reactions such as eczema, rosacea, impetigo,&#xD;
             dermatomyositis, or allergic contact dermatitis on both wrists or over electrode&#xD;
             attachment sites, including known allergy or sensitivity to silicone bands primarily&#xD;
             used in wrist-worn fitness devices;&#xD;
&#xD;
          -  Known sensitivity to medical adhesives, isopropyl alcohol, watch bands, or ECG&#xD;
             electrodes;&#xD;
&#xD;
          -  A history of abnormal life-threatening rhythms as determined by the Investigator;&#xD;
&#xD;
          -  Significant tremor that prevents subject from being able to hold still;&#xD;
&#xD;
          -  Women who are pregnant at the time of study participation; and&#xD;
&#xD;
          -  Subjects enrolled into the SR population must not have any diagnosis of AF.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Travis W Johnson</last_name>
    <phone>1-913-440-2624</phone>
    <phone_ext>2624</phone_ext>
    <email>travis.johnson@garmin.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liz K Waters</last_name>
    <phone>1-913-440-5136</phone>
    <phone_ext>5136</phone_ext>
    <email>Liz.Waters@garmin.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hope Research Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Crystal Calzadillas</last_name>
      <phone>602-288-4673</phone>
      <email>michele.aguirre@hriaz.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John A Bonilla</last_name>
      <phone>202-877-2336</phone>
      <email>john.a.bonilla@medstar.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HealthEast</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah Zwagerman</last_name>
      <phone>651-326-4448</phone>
      <email>sazwagerman@healtheast.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwell Health North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Kats</last_name>
      <phone>516-708-2558</phone>
      <email>skats@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwell Health Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Coleman</last_name>
      <phone>212-434-6500</phone>
      <email>kcoleman1@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MedStar Health Cardiac Electrophysiology at Fairfax</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John A Bonilla</last_name>
      <phone>202-877-2336</phone>
      <email>john.a.bonilla@medstar.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2021</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

